SCHEMBL4908668

SCHEMBL4908668

Cc1ccc(S(=O)(=O)N(CCc2ccc(OCc3ccc(F)cc3)cc2)Cc2ccc(F)cc2)cc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 8/20 0.49
PPARA Q07869 2/20 0.45
NR1H4 Q96RI1 1/20 0.44
NR4A2 P43354 1/20 0.44
ADAMTS4 O75173 1/20 0.43
CNR2 P34972 1/20 0.43
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
CA4 P22748 1/20 0.43
CA7 P43166 1/20 0.43
MMP9 P14780 1/20 0.42
MMP13 P45452 1/20 0.42
ADAM17 P78536 1/20 0.42
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905775 0.92 TAS2R14 (0.58) TAS2R14NR1H4CNR2CA12CA1
SCHEMBL4904466 0.92 CNR2 (0.53) TAS2R14NR1H4CNR2CA12CA1
SCHEMBL4906541 0.92 TAS2R14 (0.46) TAS2R14NR1H4CNR2CA12CA1
SCHEMBL4900038 0.91 TAS2R14 (0.46) TAS2R14ADAMTS4CA12CA1CA2
SCHEMBL4900641 0.91 MEN1 (0.54) TAS2R14NR1H4NR4A2CNR2CA12
SCHEMBL4894471 0.90 CA12 (0.48) TAS2R14PPARANR1H4ADAMTS4CA12
SCHEMBL4897933 0.89 TAS2R14 (0.46) TAS2R14PPARANR1H4CNR2CA12
SCHEMBL4898092 0.88 TAS2R14 (0.48) TAS2R14NR1H4CNR2CA12CA1
SCHEMBL4895626 0.84 TAS2R14 (0.56) TAS2R14NR1H4ADAMTS4CNR2CA12
SCHEMBL4908413 0.83 CNR2 (0.48) TAS2R14CNR2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TAS2R14 4032/4885PPARA 1/4885NR1H4 21/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TAS2R14 4032/4885PPARA 1/4885NR1H4 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.